Connor, Clark & Lunn Investment Management (CC&L)’s OrthoPediatrics KIDS Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio KIDS Stock Details KIDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-15,901	Closed	-$342K	–	1614
2025 Q2	$342K	Buy	15,901 +1,753	+12%	+$37.9K	﹤0.01%	1333
2025 Q1	$348K	Buy	14,148 +4,508	+47%	+$111K	﹤0.01%	1225
2024 Q4	$223K	Sell	9,640 -1,230	-11%	-$30.8K	﹤0.01%	1305
2024 Q3	$295K	Buy	+10,870	New	+$329K	﹤0.01%	1245
2023 Q4	–	Sell	-9,621	Closed	-$308K	–	1475
2023 Q3	$308K	Sell	9,621 -2,900	-23%	-$112K	﹤0.01%	1136
2023 Q2	$549K	Buy	+12,521	New	+$577K	﹤0.01%	965

Other funds holding KIDS

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s KIDS Position: Q3 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of OrthoPediatrics (KIDS) in Q3 2025, closing a stake of 15,901 shares — an estimated $342K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in KIDS in Q2 2023 and held it in 6 quarters. The position peaked at $549K in Q2 2023. 111 funds tracked by Wall St. Rank hold KIDS as of Q3 2025.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining OrthoPediatrics position as of Q3 2025 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 15,901 OrthoPediatrics shares in Q3 2025, an estimated $342K.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in OrthoPediatrics in Q2 2023 and held it in 6 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s OrthoPediatrics position peaked at $549K in Q2 2023.
111 funds tracked by Wall St. Rank held OrthoPediatrics as of Q3 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2025, filed 13 Nov 2025.